PARIS (EGMN) – A simple blood test could help diagnose hereditary forms of breast and ovarian cancer with BRCA1 and 2 mutations, according to data presented at the Worldwide Innovative Networking (WIN) in Personalized Cancer Medicine symposium.
PARIS (EGMN) – A simple blood test could help diagnose hereditary forms of breast and ovarian cancer with BRCA1 and 2 mutations, according to data presented at the Worldwide Innovative Networking (WIN) in Personalized Cancer Medicine symposium.